GCH1 and neoplasm: However, this result corroborates the literature data, since GCH1 expression is increased in estrogen-receptor-negative breast tumors and cells present in the tumor microenvironment, like stromal fibroblasts and inflammatory and endothelial cells, being a significant predictor of poor prognosis in patients [40].